4th Annual Toxicology Education Day


4th Annual Toxicology Education Day Banner

Add to Calendar 4th Annual Toxicology Education Day 2/19/2021 7:00:00 AM 2/19/2021 5:15:00 PM America/Mexico_City false MM/DD/YYYY


Date & Location
Friday, February 19, 2021, 7:00 AM - 5:15 PM

Overview
The 4th Annual Toxicology Education Day is a single-day conference geared toward healthcare professionals involved in the care of patients with overdoses, envenomations, or other exposures. This includes emergency medicine, critical care, family medicine, and internal medicine physicians and mid-level providers, pediatricians, pharmacists, nurses, and pre-hospital providers. The activity will be offered virtually via Zoom. Topics delivered by experts in the fields of toxicology, emergency medicine, and critical care include: initial evaluation of the poisoned patient, evaluation of available analytical toxicology tests, riot control agents, a multidisciplinary roundtable, pediatric toxidromes, discerning toxicologic causes for hyperthermia, medical marijuana and the evidence surrounding it’s use for chronic pain, aspirin overdose, common bites and stings, a high-yield review for board exams, and toxicant-related lung injuries. 


Objectives
Upon completion of this activity, participants will improve their competence and performance by being able to:

  1. Identify analytical toxicology tests available to support the management of poisoned patients presenting to emergency departments, and recognize advantages and disadvantages of commonly utilized clinical toxicology laboratory tests.
  2. Recognize the most utilized riot control agents by law enforcement and the purpose of each agent, and illustrate a treatment plan for a patient that presents with signs and symptoms after exposure to a riot control agent.
  3. Describe how healthcare providers of several different disciplines can work together in treating a poisoned patient.
  4. Recognize toxidromes based on initial physical examination findings in the pediatric patient, and Illustrate a treatment plan for a pediatric patient that presents with signs and symptoms of a particular toxidrome.
  5. Recognize the signs and symptoms associated with a large ingestion of aspirin-containing products, and illustrate a treatment plan for a patient that presents with signs and symptoms of a salicylate overdose.

Registration
Early-Bird Registration: (On or before February 1, 2020)
 $75 Physicians
$75 Pharmacists
$75 Other Healthcare Providers
$37.50 Residents/Students

Regular Registration (After February 1, 2020)
 $100 Physicians
$100 Pharmacists
$100 Other Healthcare Providers
$50 Residents/Students

Online registration and early registration are strongly recommended.
• No registration refunds will be made after February 14, 2020.
• Written notification of cancellation must be postmarked on/or before February 10, 2020.
• Cancellation Fee is $45

Accreditation

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Continuing Education
The University of Oklahoma College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education
as a provider of continuing pharmacy education. This activity is eligible for 8.0 contact hours of APCE credit.

Nursing Pharmacology
Oklahoma Board of Nursing approval of Pharmacology continuing education units are pending application approval.

Nursing Continuing Education
ANCC Accreditation Statement: OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 
CNE Disclosure Statements: OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 
8.00 CNE contact hours will be awarded for meeting the following criteria: 90% attendance of conference, completion and submission of evaluation form. 
This educational activity does not include any content that relates to products and/or services of a commercial interest that would create a conflict of interest. 

EMS:
his program has been approved for 8 hours of state-approved pre-hospital personnel CME.


Additional Information

Conflict Resolution Statement:
The University of Oklahoma College of Medicine, Office of Continuing Professional Development, OU Medicne, Inc., and College of Pharmacy have reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of
interest, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices or procedures. This includes, but is not limited to: admissions, employment, financial aid and educational services. Inquiries regarding non-discrimination policies may be directed to: Bobby J. Mason, Institutional Equity Officer, (405) 325-3546, bjm@ou.edu, or visit www.ou.edu/eoo.

Accommodation Statement:
Accommodations on the basis of disability are available by contacting Susie Dealy at (405) 271-2350 or susie-dealy@ouhsc.edu as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma, College of Medicine OU Medicne, Inc., and College of Pharmacy that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).

 


Credits
AMA PRA Category 1 Credits™ (8.25 hours), Non-Physician Attendance (8.25 hours), Accredited Continuing Pharmacy Education (8.25 hours), ANCC Nursing Contact Hours (8.25 hours), OBN Pharmacology Contact Hours (Category B) (8.10 hours), EMS/Pre-Hospital (8.00 hours)